PRX012

Prothena leverages Walgreens’ capabilities to accelerate development of Alzheimer’s Drug
Medical Marketing and Media
Sun, 04/16/23 - 11:15 pm
Prothena
PRX012
fast track
Walgreens
clinical trials
FDA grants Prothena fast track designation for Alzheimer’s disease therapy
Biopharma Reporter
Tue, 05/3/22 - 10:46 am
Prothena
FDA
fast track
Alzheimer's status
PRX012
Prothena rolls out preclinical data for anti-amyloid Alzheimer's candidate to rival Biogen's Aduhelm
Fierce Biotech
Mon, 07/26/21 - 10:09 pm
Prothena
Alzheimer's disease
monoclonal antibodies
Biogen
Aduhelm
PRX012